Comparison of Adherence and Persistence Associated with First-Line Disease-Modifying Therapies among Patients with Multiple Sclerosis

被引：0
|
作者：
Halpern, Rachel
Agarwal, Sonalee
Borton, Leigh A.
Babic, Tomislav
机构：
来源：
NEUROLOGY | 2010年 / 74卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A547 / A548
页数：2
相关论文
共 50 条
  • [31] Adherence to Multiple Sclerosis Disease-Modifying Therapies in Ontario Is Low
    Wong, Janice
    Gomes, Tara
    Mamdani, Muhammad
    Manno, Michael
    O'Connor, Paul W.
    NEUROLOGY, 2011, 76 (09) : A465 - A465
  • [32] Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations
    Evans, Charity
    Marrie, Ruth Ann
    Zhu, Feng
    Leung, Stella
    Lu, Xinya
    Kingwell, Elaine
    Zhao, Yinshan
    Tremlett, Helen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (06) : 702 - 711
  • [33] First-Line Disease-Modifying Therapies in Paediatric Multiple SclerosisA Comprehensive Overview
    Jessica Johnston
    Tsz-Yin So
    Drugs, 2012, 72 (9) : 1195 - 1211
  • [34] The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis
    Pardo, Gabriel
    Pineda, Elmor D.
    Ng, Carmen D.
    Sheinson, Daniel
    Bonine, Nicole G.
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2022, 9 (01): : 111 - 116
  • [35] Persistence and adherence to disease modifying drugs among patients with multiple sclerosis
    Reynolds, Matthew W.
    Stephen, Reejis
    Seaman, Chris
    Rajagopalan, Kitty
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) : 663 - 674
  • [36] Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis
    Coerver, E. M. E.
    Bourass, A.
    Wessels, M. H. J.
    van Kempen, Z. L. E.
    Jasperse, M. M. S.
    Tonino, B. A. R.
    Barkhof, F.
    Mostert, J.
    Uitdehaag, B. M. J.
    Killestein, J.
    Strijbis, E. M. M.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 74
  • [37] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [38] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
  • [39] Real-world persistence of multiple sclerosis disease-modifying therapies
    Tallantyre, Emma C.
    Dobson, Ruth
    Froud, Joseph L. J.
    St John, Frederika A.
    Anderson, Valerie M.
    Arun, Tarunya
    Buckley, Lauren
    Evangelou, Nikos
    Ford, Helen L.
    Galea, Ian
    George, Sumi
    Gray, Orla M.
    Hibbert, Aimee M.
    Hu, Mo
    Hughes, Stella E.
    Ingram, Gillian
    Kalra, Seema
    Lim, Chia-Hui E.
    Mathews, Joela T. M.
    McDonnell, Gavin V.
    Mescall, Naomi
    Norris, Sam
    Ramsay, Stephen J.
    Rice, Claire M.
    Russell, Melanie J.
    Shawe-Taylor, Marianne J.
    Williams, Thomas E.
    Harding, Katharine E.
    Robertson, Neil P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [40] Disease-modifying therapies for multiple sclerosis
    John R. Corboy
    Douglas S. Goodin
    Elliot M. Frohman
    Current Treatment Options in Neurology, 2003, 5 (1) : 35 - 54
12345